Wildi, K., Bihari, S., Bersten, A., Dixon, D., Paul, E., McGuinness, S., Hodgson, C., Nichol, A., Chataway, T., Colella, A., Gebhard, C., Chegeni, N., Matigian, N., LiBassi, G., Passmore, M., Bouquet, M., Ritchie, A., Suen, J., Fraser, J. Scientific Reports DOI: 10.1038/s41598-026-43956-0
Abstract: Protein pathways underlying ARDS phenotypes are not fully elucidated. The aim of this subanalysis of an international randomized controlled clinical trial, which assessed the potential benefit of a maximal lung recruitment strategy, was to identify protein signatures in serum and bronchoalveolar fluid associated with ARDS phenotypes and to improve understanding of the underlying biological pathways.